Medgenics (MDGN) Misses Q3 EPS by 31c
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q3 EPS of ($0.66), $0.31 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
